Expertise in
12
conditions

Hansjurgen T. Agostini

Freiburg, BW, DE 
Expertise in
12
conditions
Freiburg, BW, DE 

Overview

Hansjurgen Agostini practices practicing medicine in Freiburg, Germany.

Agostini is highly rated in 12 conditions, according to our data. Their clinical expertise encompasses Hemangioblastoma, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

They are actively involved in clinical research, co-authoring 153 peer reviewed articles and participating in 2 clinical trials.

Locations

Freiburg, BW, Germany
Other Locations
Salem, BW, Germany
Tuebingen, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Development of Novel Clinical Endpoints for Interventional Clinical Trials With a Regulatory and Patient Access Intention in Patients With Intermediate Age-related Macular Degeneration (AMD)
Development of Novel Clinical Endpoints for Interventional Clinical Trials With a Regulatory and Patient Access Intention in Patients With Intermediate Age-related Macular Degeneration (AMD)
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Other
Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Drug
Study Drugs: 5-Fluorouracil, Low molecular weight heparin
Study Phase: Phase 3
View 1 Less Clinical Trial

153 Total Publications

Visual Prognosis and Treatment of Ruptured Eyes after Blunt Globe Rupture.
Visual Prognosis and Treatment of Ruptured Eyes after Blunt Globe Rupture.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: February 26, 2026

Frequently Asked Questions about Hansjurgen T. Agostini

Is Hansjurgen T. Agostini a top-rated expert for Hemangioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Hansjurgen T. Agostini is classified as an Distinguished expert for Hemangioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hansjurgen T. Agostini participate in research or clinical trials?

Yes. Hansjurgen T. Agostini has published 153 articles and abstracts on conditions like Hemangioblastoma. You can view a list of Hansjurgen T. Agostini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Agostini's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile